Position in MRNA
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$271,716
-$102,584 QoQ
Shares Held
3,880
+23.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#455
of 772 holders
Holding Since
Sep 2021
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Frank, Rimerman Advisors LLC holds $4,627,199 across 8 Biotechnology names. MRNA ranks #8 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,373 | $1,675,470 | |
| 2 | ARGX |
Argenx SE
|
649 | $602,122 | |
| 3 | RPRX |
Royalty Pharma plc
|
10,493 | $588,342 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
5,807 | $460,437 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,228 | $369,664 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
570 | $355,417 | |
| 7 | INCY |
Incyte Corp
|
2,682 | $304,031 | |
| 8 | MRNA |
Moderna, Inc.
This page
|
3,880 | $271,716 |
All Filings in MRNA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $271,716 | 3,880 | Shares | Sole | 2026-07-27 | |
| 2024-06-30 | $374,300 | 3,152 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $74,698 | 701 | Shares | Sole | 2024-05-09 | |
| 2021-09-30 | $213,982 | 556 | Shares | Sole | 2023-09-07 | |
| No filing history on record for this holder in this stock. | ||||||